Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: A prospective cohort study

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Strand, Elin ^a   Pedersen, Eva R ^a   Svingen, Gard F T ^a   Schartum Hansen, Hall ^b   Rebnord, Eirik W ^b   Bjørndal, Bodil ^a   Seifert, Reinhard ^b   Bohov, Pavol ^a   Meyer, Klaus ^c   Hiltunen, J K ^d,e   Nordrehaug, Jan E ^a,b   Nilsen, Dennis W T ^a,f   Berge, Rolf K ^a,b,e   Nygård, Ottar ^a,b,e  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c BEVITAL AS   (Norway)

^d UNIVERSITY OF OULU   (Finland)

^e MitoHealth Centre for Bioactive Food Components and Prevention of Lifestyle Diseases   (Norway)

^f STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Coronary artery disease; Diabetes; Dietary n 3 fatty acids; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COD LIVER OIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; FOLIC ACID; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; METFORMIN; OMEGA 3 FATTY ACID; PYRIDOXINE; SULFONAMIDE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DIET RESTRICTION; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; NORWAY; NUTRITIONAL ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; FOLIC ACID; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; PROSPECTIVE STUDIES; RISK FACTORS; SEAFOOD;

EID: 84887911245     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-216     Document Type: Article

References (45)

1. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296(15):1885-1899. 10.1001/jama.296.15.1885, 17047219.
2. Roth EM, Harris WS. Fish oil for primary and secondary prevention of coronary heart disease. Curr Atheroscler Rep 2010, 12(1):66-72. 10.1007/s11883-009-0079-6, 20425273.
3. Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003, 23(2):151-152. 10.1161/01.ATV.0000057393.97337.AE, 12588750.
4. Kwak SM, Myung SK, Lee YJ, Seo HG. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 2012, 172(9):686-694. 10.1001/archinternmed.2012.262, 22493407.
5. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012, 308(10):1024-1033. 10.1001/2012.jama.11374, 22968891.
6. Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Marzona I, Milani V, Silletta MG, Tognoni G, Marchioli R, Risk and Prevention Study Collaborative Group n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 2013, 368(19):1800-1808. Risk and Prevention Study Collaborative Group.
7. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372(9645):1223-1230. 10.1016/S0140-6736(08)61239-8, 18757090.
8. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 2011, 57(7):870-879. 10.1016/j.jacc.2010.11.017, 21215550.
9. Ghio S, Scelsi L, Latini R, Masson S, Eleuteri E, Palvarini M, Vriz O, Pasotti M, Gorini M, Marchioli R, Maggioni A, Tavazzi L, GISSI-HF investigators Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 2010, 12(12):1345-1353. 10.1093/eurjhf/hfq172, 20952767, GISSI-HF investigators.
10. Deaton C, Mamas MA, Rutter MK, Gibson M, Bowell S, Byrne R, Coezy K, Gow J, Williams S. Glucose and insulin abnormalities in patients with heart failure. Eur J Cardiovasc Nurs 2011, 10(2):75-87. 10.1016/j.ejcnurse.2010.08.007, 20956089.
11. Fallow GD, Singh J. The prevalence, type and severity of cardiovascular disease in diabetic and non-diabetic patients: a matched-paired retrospective analysis using coronary angiography as the diagnostic tool. Mol Cell Biochem 2004, 261(1-2):263-269.
12. Hu FB, van Dam RM, Liu S. Diet and risk of Type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001, 44(7):805-817. 10.1007/s001250100547, 11508264.
13. Nkondjock A, Receveur O. Fish-seafood consumption, obesity, and risk of type 2 diabetes: an ecological study. Diabetes Metab 2003, 29(6):635-642. 10.1016/S1262-3636(07)70080-0, 14707894.
14. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willett WC. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001, 73(6):1019-1026.
15. Meyer KA, Kushi LH, Jacobs DR, Folsom AR. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001, 24(9):1528-1535. 10.2337/diacare.24.9.1528, 11522694.
16. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003, 78(1):91-98.
17. van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002, 25(3):417-424. 10.2337/diacare.25.3.417, 11874924.
18. Bosch J, Gerstein HC, Dagenais GR, Diaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S, ORIGIN Trial Investigators n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012, 367(4):309-318. ORIGIN Trial Investigators.
19. Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedewald WT, Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358(24):2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
20. Manger MS, Strand E, Ebbing M, Seifert R, Refsum H, Nordrehaug JE, Nilsen DW, Drevon CA, Tell GS, Bleie O, Vollset SE, Pedersen ER, Nygård O. Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. Am J Clin Nutr 2010, 92(1):244-251. 10.3945/ajcn.2010.29175, 20484456.
21. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygard O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008, 300(7):795-804. 10.1001/jama.300.7.795, 18714059.
22. Andersen LF, Solvoll K, Drevon CA. Very-long-chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. Am J Clin Nutr 1996, 64(3):305-311.
23. Andersen LF, Solvoll K, Johansson LR, Salminen I, Aro A, Drevon CA. Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol 1999, 150(1):75-87. 10.1093/oxfordjournals.aje.a009921, 10400557.
24. Biroccio A, Urbani A, Massoud R, di Ilio C, Sacchetta P, Bernardini S, Cortese C, Federici G. A quantitative method for the analysis of glycated and glutathionylated hemoglobin by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Anal Biochem 2005, 336(2):279-288. 10.1016/j.ab.2004.10.002, 15620893.
25. Strand E, Bjorndal B, Nygard O, Burri L, Berge C, Bohov P, Christensen BJ, Berge K, Wergedahl H, Viste A, Berge RK. Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat. Lipids Health Dis 2012, 11(1):82. 10.1186/1476-511X-11-82, 3459737, 22738017.
26. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150(9):604-612. 10.7326/0003-4819-150-9-200905050-00006, 2763564, 19414839, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).
27. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36(3):959-969. 10.1016/S0735-1097(00)00804-4, 10987628.
28. Inzucchi SE. Clinical practice. Diagnosis of diabetes. N Engl J Med 2012, 367(6):542-550. 10.1056/NEJMcp1103643, 22873534.
29. Verification SSoB Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002, 4(2):149-159. 10.1080/14622200210123581, 12028847, Verification SSoB.
30. Berstad P, Konstantinova SV, Refsum H, Nurk E, Vollset SE, Tell GS, Ueland PM, Drevon CA, Ursin G. Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland Homocysteine Study. Am J Clin Nutr 2007, 85(6):1598-1605.
31. Kromhout D, Giltay EJ, Geleijnse JM. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010, 363(21):2015-2026. 10.1056/NEJMoa1003603, 20929341.
32. Kromhout D, Geleijnse JM, de Goede J, Oude Griep LM, Mulder BJ, de Boer MJ, Deckers JW, Boersma E, Zock PL, Giltay EJ. n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. Diabetes Care 2011, 34(12):2515-2520. 10.2337/dc11-0896, 3220851, 22110169.
33. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004, 109(22):2705-2711. 10.1161/01.CIR.0000132503.19410.6B, 15184295.
34. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y, Tsugane S. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006, 113(2):195-202. 10.1161/CIRCULATIONAHA.105.581355, 16401768.
35. de Goede J, Geleijnse JM, Boer JM, Kromhout D, Verschuren WM. Marine (n-3) fatty acids, fish consumption, and the 10-year risk of fatal and nonfatal coronary heart disease in a large population of Dutch adults with low fish intake. J Nutr 2010, 140(5):1023-1028. 10.3945/jn.109.119271, 20335635.
36. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D, Manson JE. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002, 287(14):1815-1821. 10.1001/jama.287.14.1815, 11939867.
37. Eussen SR, Geleijnse JM, Giltay EJ, Rompelberg CJ, Klungel OH, Kromhout D. Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction. Eur Heart J 2012, 33(13):1582-1588. 10.1093/eurheartj/ehr499, 3388014, 22301766.
38. Golomb BA, Erickson LC, Koperski S, Sack D, Enkin M, Howick J. What's in placebos: who knows? Analysis of randomized, controlled trials. Ann Intern Med 2010, 153(8):532-535. 10.7326/0003-4819-153-8-201010190-00010, 20956710.
39. Bresson JL, Flynn A, Heinonen M, Hulshof K, Korhonen H, Lagiou P, Løvik M, Marchelli R, Martin A, Moseley B, Przyrembel H, Salminen S, Strain S(JJ), Strobel S, Tetens I, van den Berg H, van Loveren H, Verhagen H. Scientific Opinion of the Panel on Dietetic products, Nutrition and Allergies on a request from European Commission related to labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids. EFSA Journal 2009, 1176:1-11.
40. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NA, Elwood PC. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003, 57(2):193-200. 10.1038/sj.ejcn.1601539, 12571649.
41. Billman GE, Carnes CA, Adamson PB, Vanoli E, Schwartz PJ. Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation: lack of protection and a proarrhythmic effect. Circ Arrhythm Electrophysiol 2012, 5(3):553-560. 10.1161/CIRCEP.111.966739, 3380163, 22333345.
42. Aggarwal V, Schneider AL, Selvin E. Low hemoglobin A(1c) in nondiabetic adults: an elevated risk state?. Diabetes Care 2012, 35(10):2055-2060. 10.2337/dc11-2531, 3447844, 22855733.
43. Wang J, Alexanian A, Ying R, Kizhakekuttu TJ, Dharmashankar K, Vasquez-Vivar J, Gutterman DD, Widlansky ME. Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler Thromb Vasc Biol 2012, 32(3):712-720. 10.1161/ATVBAHA.111.227389, 3319449, 22207730.
44. Vigerust NF, Cacabelos D, Burri L, Berge K, Wergedahl H, Christensen B, Portero-Otin M, Viste A, Pamplona R, Berge RK, Bjørndal B. Fish oil and 3-thia fatty acid have additive effects on lipid metabolism but antagonistic effects on oxidative damage when fed to rats for 50 weeks. J Nutr Biochem 2012, 23(11):1384-1393. 10.1016/j.jnutbio.2011.08.006, 22221672.
45. Miinalainen IJ, Schmitz W, Huotari A, Autio KJ, Soininen R, Ver Loren van Themaat E, Baes M, Herzig KH, Conzelmann E, Hiltunen JK. Mitochondrial 2,4-dienoyl-CoA reductase deficiency in mice results in severe hypoglycemia with stress intolerance and unimpaired ketogenesis. PLoS Genet 2009, 5(7):e1000543. 10.1371/journal.pgen.1000543, 2697383, 19578400.